Resverlogix’s Apabetalone Demonstrates a Medical First in Patients with Chronic Kidney Disease

NEXT STORY
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
PREV STORY
CORRECTION: Composition of the Nomination Committee of Orion Corporation
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Generex Biotechnology Announces First Patient Enrolled in the Phase II Clinical Trial of AE37 in Combination with Pembrolizumab (Keytruda®) for the Treatment of Triple Negative Breast Cancer

author_avatar
NASDAQ Market News

Maru/Matchbox Appoints Industry Veteran, Rich Durante as Managing Director, Pharmaceuticals and Medicines

author_avatar
NASDAQ Market News

Healthy Extracts to Exhibit its Clinically Proven Formulations for Women’s Health at the Women’s Wellness Expo, December 4, 2021

author_avatar
NASDAQ Market News